These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1507428)

  • 21. [MRSA infections in neonates and premature infants].
    Sunakawa K; Yokota T; Nitta Y
    Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1646-51. PubMed ID: 1469316
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
    Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRSA meningitis and intrathecal injection of arbekacin.
    Fujita T; Kayama T; Sato I; Fukai H; Sobue H; Nakai O
    Surg Neurol; 1997 Jul; 48(1):69. PubMed ID: 9199688
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
    Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
    Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
    Araake M; Hara T; Miyata A; Tani M; Ogawa H
    Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Revaluation of current antimicrobials. Series 17: Arbekacin sulfate].
    Hayashi I; Inoue M
    Jpn J Antibiot; 1994 Oct; 47(10):1267-74. PubMed ID: 7807688
    [No Abstract]   [Full Text] [Related]  

  • 28. [New antimicrobial agent series XL: arbekacin].
    Niijima T
    Jpn J Antibiot; 1991 Jul; 44(7):705-17. PubMed ID: 1886198
    [No Abstract]   [Full Text] [Related]  

  • 29. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
    You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
    Hayashi I; Inoue M; Hashimoto H
    Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
    Yanagisawa C; Hanaki H; Oishi T; Uehara K; Yamaguchi Y; Matui H; Sunakawa K
    Jpn J Antibiot; 2005 Feb; 58(1):11-6. PubMed ID: 15847221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
    Aoki Y
    Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
    Hijioka S; Nakata R; Yoshinami Y; Sugita K; Nishimura T
    Jpn J Antibiot; 2002 Dec; 55(6):764-70. PubMed ID: 12621730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
    Hiramatsu K; Hanaki H; Ino T; Yabuta K; Oguri T; Tenover FC
    J Antimicrob Chemother; 1997 Jul; 40(1):135-6. PubMed ID: 9249217
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
    Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
    Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
    Hayashi I; Inoue M; Hashimoto H
    Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Appropriate use of anti-methicillin-resistant Staphylococcus aureus agents in a retrospective study].
    Nakamura Y; Yokoyama I; Hashimoto N; Hasegawa A; Nakasa H; Nakamura H; Watanabe M; Nomura F; Watanabe A; Igari H; Sato T; Nakazawa K; Ariyoshi N; Kitada M
    Yakugaku Zasshi; 2008 Jul; 128(7):1073-9. PubMed ID: 18591876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
    Lee J; Kim CK; Roh KH; Lee H; Yum JH; Yong D; Lee K; Chong Y
    Korean J Lab Med; 2007 Aug; 27(4):292-7. PubMed ID: 18094591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.